https://orcid.org/0000-0001-6170-1001
References
- Chen J, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen. 1999;7:79–89. doi:10.1046/j.1524-475X.1999.00079.x
- Ortonne JP. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J Dermatolog Treat. 1996;7:75–81. doi:10.3109/09546639609089533
- Liguori V, Guillemin C, Pesce GF, Mirimanof RO, Bernier J. Double‐blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol. 1997;42:155–161. doi:10.1016/S0167-8140(96)01882-8
- Nolan A, Baillie C, Badminton J, Rudralingham M, Seymour RA. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. J Oral Pathol Med. 2006;35(8):461–465. doi:10.1111/jop.2006.35.issue-8
- Yamada S, Sugahara K. Potential therapeutic application of chondroitin sulphate/dermatan sulphate. Curr Drug Discov Technol. 2008;5(4):289–301. doi:10.2174/157016308786733564
- Volpi N. Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule. Inflammopharmacology. 2011;19(6):299–306. doi:10.1007/s10787-011-0098-0
- Bonfils S, Dubrasquet M, Lambling A. The inhibition of peptic proteolysis by various polysaccharides. Rev Fr Etud Clin Biol. 1960;5:71–74.
- Galzigna L, Previerocoletti MA. Action of sodium chondroitin sulphate on the enzymatic activity of pepsin. Gazz Med Ital. 1965;124:65.
- Lenzi G, Rapino P, Ferri S. On the behavior of gastric hydrochloric and peptic activity after administration of sodium chondroitin sulphate. Minerva Med. 1963;54:3421–3424.
- Baldini E, Tincani GP. Treatment of gastroduodenal ulcer with sodium chondroitin sulphate. Minerva Gastroenterol. 1963;9:25–29.
- Griesinger C, Desprez B, Coecke S, Casey W Zuang V. Validation of alternative in vitro methods to animal testing: concepts, challenges, processes and tools. Adv Exp Med Biol. 2016;856:65–132.
- Palmieri B, Corbascio D, Capone S, Lodi D. Preliminary clinical experience with a new natural compound in the treatment of esophagitis and gastritis: symptomatic effect. Trends Med. 2009;9:219–225.
- Palmieri B, Merighi A, Corbascio D, Rottigni V, Fistetto G, Esposito A. Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo-controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux. Eur Rev Med Pharmacol Sci. 2013;17:3272–3278.
- Savarino V, Pace F, Scarpignato C; Esoxx Study Group. Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease – efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. Aliment Pharmacol Ther. 2017;45:631–642. doi:10.1111/apt.13914
- Iannitti T, Laurino C, Morales JC, et al. A chondroitin sulphate and hyaluronic acid-based dietary formulation improves non-erosive gastroesophageal reflux disease-related symptoms and gastric juice-related biochemical parameters: an open-label uncontrolled study. Adv Health Dis. 2017;1:43–61.
- Casas JW, Lewerenz GM, Rankin EA, et al. In vitro human skin irritation test for evaluation of medical device extracts. Toxicol In Vitro. 2013;27:2175–2183. doi:10.1016/j.tiv.2013.08.006
- Kandarova H, Willoughby JA, De Jong WH, et al. Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™. Toxicol In Vitro. 2018;50:407–417. doi:10.1016/j.tiv.2018.02.007
- De Jong WH, Hoffmann S, Lee M, et al. Round robin study to evaluate the reconstructed human epidermis (RhE) model as an in vitro skin irritation test for detection of irritant activity in medical device extracts. Toxicol In Vitro. 2018;50:439–449. doi:10.1016/j.tiv.2018.01.001